Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Oak vs Remi Meds

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #114Desk pick
Oak

Nationwide, package-based and quick to approve, at $200/mo for compounded semaglutide and $250 for tirzepatide — one flat rate at every dose. The catch is not secrecy but inconsistency: its advertising carries nine different "starting" prices and none of them is what it charges.

$250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $200/mo that morning sema · $300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $250/mo that morning tirz · Verified August 8, 2026

Marked down on: Oak's MARKETING layer publishes nine different "starting" figures — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and attaches a term or billing cadence to none of them. None of the nine is what it charges: its own funnel quotes $200/mo semaglutide and $250/mo tirzepatide, one flat rate at every dose

vs
Dispatch #338
Remi Meds

Remi Meds is a DTC compounded-GLP-1 telehealth platform offering per-dose-tier compounded semaglutide and tirzepatide-with-B12, plus NAD+, Sermorelin, and Glutathione add-ons.

$249/mo (0.25 mg dose, compounded) sema · $349/mo (2.25 mg dose, compounded) tirz · Verified July 25, 2026

Marked down on: No named medical director, founder, or physician on any public page

Oak takes this head-to-head with the higher Desk Score, 71/100 (C) against 58/100 (C) for Remi Meds. Remi Meds still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Oak

71/100

C

Overall

Remi Meds

58/100

C

Price transparency

45
78

State access

95
24

Molecule range

62
72

Onboarding speed

92
50

Support responsiveness

72
58

Licensing & trust

70
59

The spec sheet

FieldOakRemi Meds
Semaglutide$250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $200/mo that morning$249/mo (0.25 mg dose, compounded)
Tirzepatide$300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $250/mo that morning$349/mo (2.25 mg dose, compounded)
CoverageAll 50 statesNot listed on Remi Meds's site (checked July 25, 2026)
Brand-nameCompounded onlyCompounded only
Oral optionInjectable onlyInjectable only
Best forPeople who want nationwide package-based care and are willing to complete a long intake before learning what they will actually pay.Per-dose-tier compounded GLP-1 with named Strive Pharmacy partner.
Desk Score71/100C58/100C

The verdict

Desk pick — Oak

Oak takes this head-to-head with the higher Desk Score, 71/100 (C) against 58/100 (C) for Remi Meds. Remi Meds still holds its ground where its strengths line up with yours.

Choose Oak if…

People who want nationwide package-based care and are willing to complete a long intake before learning what they will actually pay.

$250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $200/mo that morning sema · $300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $250/mo that morning tirz · All 50 states

Choose Remi Meds if…

Per-dose-tier compounded GLP-1 with named Strive Pharmacy partner.

$249/mo (0.25 mg dose, compounded) sema · $349/mo (2.25 mg dose, compounded) tirz

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Oak · Remi Meds.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.